TKD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 26.05 EUR Market Closed

Market Cap: €40.9B

T	Takeda Pharmaceutical Co Ltd XBER:TKD	JP
	Belden Inc NYSE:BDC	US
	EPR Properties F:E2H	US
H	Helix Energy Solutions Group Inc XMUN:CTV	US
I	Insperity Inc XBER:ASF	US
E	Erste Group Bank AG XMUN:EBO	AT
S	Sky ICT PCL SET:SKY	TH
A	Alpha IVF Group Bhd KLSE:ALPHA	MY
A	Amada Co Ltd XMUN:AA2	JP
	Vranken Pommery Monopole SA PAR:POMRY	FR
	Univest Financial Corp F:UVE	US

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

13% > 3%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

7% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.